Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (39)
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
1951 • 319,299 citations
Enzyme kinetics; behavior and analysis of rapid equilibrium and steady state enzyme systems
1994 • 3,007 citations
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
1994 • 2,716 citations
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
1998 • 826 citations
Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*
1996 • 598 citations
Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.
1990 • 487 citations
Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver
1989 • 480 citations
Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.
1987 • 475 citations
Human liver carbamazepine metabolism
1994 • 428 citations
First-pass metabolism of cyclosporin by the gut
1991 • 425 citations
Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
1990 • 402 citations
Cooperativity in Oxidations Catalyzed by Cytochrome P450 3A4
1997 • 380 citations
Interaction between grapefruit juice and midazolam in humans*
1995 • 360 citations
Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.
1994 • 350 citations
Disposition of intravenous and oral cyclosporine after administration with grapefruit juice*
1995 • 349 citations
Activation of CYP3A4: Evidence for the Simultaneous Binding of Two Substrates in a Cytochrome P450 Active Site
1994 • 348 citations
Expression of Modified Human Cytochrome P450 3A4 in Escherichia coli and Purification and Reconstitution of the Enzyme
1993 • 341 citations
Cyclosporin Clinical Pharmacokinetics
1993 • 338 citations
Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction
1992 • 337 citations
Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin
1996 • 280 citations
The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*
1995 • 275 citations
The pharmacokinetics of midazolam in man
1981 • 273 citations
Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
1995 • 270 citations
Verapamil
1989 • 254 citations
The Kinetics of Aflatoxin B1Oxidation by Human cDNA-Expressed and Human Liver Microsomal Cytochromes P450 1A2 and 3A4
1996 • 247 citations
Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.
1994 • 221 citations
Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
1996 • 191 citations
The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
1996 • 173 citations
Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
1996 • 157 citations
Expression of Cytochrome-P450-3A5 in Escherichia Coli: Effects of 5′ Modification, Purification, Spectral Characterization, Reconstitution Conditions, and Catalytic Activities
1995 • 141 citations
Roles of Divalent Metal Ions in Oxidations Catalyzed by Recombinant Cytochrome P450 3A4 and Replacement of NADPH-Cytochrome P450 Reductase with Other Flavoproteins, Ferredoxin, and Oxygen Surrogates
1995 • 128 citations
Role of phospholipids in reconstituted cytochrome P 450 3A form and mechanism of their activation of catalytic activity
1992 • 124 citations
Felodipine kinetics in healthy men
1985 • 114 citations
Detection of a CYP3A5 Allelic Variant: A Candidate for the Polymorphic Expression of the Protein?
1996 • 84 citations
cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
1994 • 83 citations
Human Alfentanil Metabolism by Cytochrome P450 3A3/4. An Explanation for the Interindividual Variability in Alfentanil Clearance?
1993 • 70 citations
Population pharmacokinetics of terfenadine.
1996 • 26 citations
Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability.
1996 • 24 citations
Volume 317, Number 2 (1995), in the article "Expression of Cytochrome P450-3A5 in Escherichia-Coli: Effects of 5′ Modification, Purification, Spectral Characterization, Reconstitution Conditions, and Catalytic Activities," by Elizabeth M. J. Gillam, Zuyu Guo, Yuane-Fang Ueng, Hiroshi Yamazaki, Ian Cock, Paul E. B. Reilly, Wage D. Hooper, and F. Peter Guengerich pp374-384
1995 • 15 citations
Cited By (0)
No citing papers found in database